What's new

Referral: Mysimba, naltrexone,bupropion Article 20 procedures CHMP opinion, 27/03/2025, 28/03/2025

Referral: Mysimba, naltrexone,bupropion Article 20 procedures CHMP opinion, 27/03/2025, 28/03/2025

Mar 28, 2025 - 12:00
 0
Referral: Mysimba, naltrexone,bupropion Article 20 procedures CHMP opinion, 27/03/2025, 28/03/2025
Referral: Mysimba, naltrexone,bupropion Article 20 procedures CHMP opinion, 27/03/2025, 28/03/2025
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Kisunla, donanemab, St...

Next Article

Summary of opinion: Calquence, 27/03/2025 Positive

Related Posts

Summary of opinion: Imfinzi, 27/02/2025 Positive

Summary of opinion: Imfinzi, 27/02/2025 Positive

Feb 28, 2025  0

Guideline on assessment and reporting of mechanistic models used in the context of model informed drug development

Guideline on assessment and reporting of mechanistic mo...

Feb 14, 2025  0

Orphan designation: Trehalose Treatment of neuronal ceroid lipofuscinosis, 19/10/2020 Withdrawn

Orphan designation: Trehalose Treatment of neuronal cer...

Mar 12, 2025  0